Your genes could guide your meds: new registry aims to reduce drug side effects

NCT ID NCT06726590

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study is building a registry of genetic and health information from 3,000 people with conditions like diabetes, high cholesterol, cancer, and heart disease. The goal is to help doctors choose the safest and most effective medications based on a person's genetic makeup. Participants will provide blood and urine samples and have their medications reviewed to track any side effects.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could help doctors personalize medication choices based on a patient's genetics, reducing side effects and improving treatment effectiveness.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test a new drug or therapy, so direct patient benefits may take years to realize.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVERSE DRUG REACTION (ADR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Texas A&M Family Care

    RECRUITING

    Bryan, Texas, 77802, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.